Logo-apb
Adv Pharm Bull. 2022;12(2): 262-273. doi: 10.34172/apb.2022.027
PMID: 35620343        PMCID: PMC9106967

Review Article

CRISPER/CAS System, a Novel Tool of Targeted Therapy of Drug-Resistant Lung Cancer

Vahid Akbari Kordkheyli 1 ORCID, Mohsen Rashidi 2, Yasaman Shokri 3, Samane Fallahpour 3, Atena Variji 3, Ehsan Nabipour Ghara 4, Sayed Mostafa Hosseini 5 * ORCID

Cited by CrossRef: 1


1- Mirabedini S, Musavi H, Makhlough A, Hashemi-Sooteh M, Zargari M. Association of S19W polymorphism in APOA5 gene and serum lipid levels in patients with type 2 diabetic nephropathy. 2023;44(3):243 [Crossref]
2- Zhang Z, Wang H, Yan Q, Cui J, Chen Y, Ruan S, Yang J, Wu Z, Han M, Huang S, Zhou Q, Zhang C, Hou B. Genome-wide CRISPR/Cas9 screening for drug resistance in tumors. Front Pharmacol. 2023;14 [Crossref]